Neuralink: Elon Musk’s company could not put a chip in people’s brains, 17 thousand doctors asked to know the whole thing

Large numbers of doctors are mobilizing against Tesla owner Elon Musk’s major ‘Neuralink’ project. An advocacy group of more than 17,000 doctors in the US has petitioned the Food and Drug Administration (FDA) to disqualify Neuralink from approving brain implants. Recently, Elon Musk announced that his new ‘Neuralink’ brain chip interface will be ready for human testing in the next 6 months. According to this, the tests will be carried out by placing a chip in the brain of humans. The company has been doing this animal trial for a long time. In the past, it had sought US government approval for human trials.
According to media reports, the Physicians Committee for Responsible Medicine (PCRM) claims that Neuralink violated “Good Laboratory Practice” (GLP) standards. Protocols were not fully followed during animal testing.

‘Neuralink’ is developing a device that will be able to control people’s computers, mobile phones or other devices directly with brain activity, that is, you will be able to operate your smartphone just by thinking. The maximum benefit of this device will be for the disabled and people who are trapped by paralysis.

Musk’s Neurolink says his goal is to make life easier for people suffering from neurological disorders, though it’s not yet known how successful he will be. In early February, Neuralink had revealed that many monkeys had also died during the experiment. The company was accused of animal cruelty. Although Musk dismissed the accusations.

Now with the mobilization of a large number of doctors, the gaze of the experts is on the FDA. If Elon Musk does not get FDA approval, this great Elon Musk project will be put on hold. The startup may have to start the entire project from scratch.

Even if human trials are allowed, all will not be smooth sailing for Musk’s company. If someone loses their life during the trial, Musk and his company may have to bear the brunt. Elon Musk wanted him to obtain the necessary approval to conduct human trials by 2020, although the project is 2 years behind schedule.

Leave a Comment